USMLE Step 2 CK: Endocrinology – Hypothyroidism and Myxedema Coma – Diagnosis, Levothyroxine, ICU Care

What This Is and Why It Matters for USMLE

Hypothyroidism and Myxedema Coma is a high-yield topic for Step 1, Step 2 CK, and Step 3. It's a classic presentation in internal medicine and critical care, with high-yield for Step 1 and Step 2 CK. You'll see it in basic science, clinical, and ethics/management contexts.

High-Yield Facts (What You Must Memorize)

• Pathophysiology: Reduced thyroid hormone production leads to decreased metabolic rate, weight gain, fatigue, and cold intolerance.
• Classic presentation and physical exam findings:
  • Dry skin
  • Hair loss
  • Cold intolerance
  • Weight gain
  • Fatigue
  • Bradycardia
• Diagnostic approach:
  • TSH (Thyroid-Stimulating Hormone) test: Elevated in primary hypothyroidism
  • Free T4 (FT4) and Free T3 (FT3) tests: Low in primary hypothyroidism
  • Thyroid autoantibodies: Presence suggests autoimmune thyroiditis
• First-line treatment and management:
  • Levothyroxine (T4) replacement therapy: Corrects hypothyroidism and prevents complications
  • Monitor TSH and thyroid function tests: Adjust levothyroxine dose as needed
• Red flags, complications, and follow-up:
  • Myxedema coma: Life-threatening complication of untreated hypothyroidism
  • Heart failure: Increased risk in untreated hypothyroidism
  • Regular follow-up: Monitor thyroid function and adjust treatment as needed

Clinical Pearls & Buzzwords

• Myxedema coma
• Thyroid-stimulating hormone (TSH)
• Levothyroxine (T4) replacement therapy
• Autoimmune thyroiditis

Step-by-Step Clinical Reasoning

1. Identify the syndrome or presentation: Recognize classic symptoms of hypothyroidism (dry skin, hair loss, cold intolerance, weight gain, fatigue, bradycardia)
2. Generate a differential (most likely and must-not-miss):
   • Primary hypothyroidism
   • Secondary hypothyroidism
   • Thyroiditis
   • Pituitary disease
3. Order appropriate initial tests:
   • TSH test
   • Free T4 (FT4) and Free T3 (FT3) tests
   • Thyroid autoantibodies
4. Interpret results:
   • Elevated TSH suggests primary hypothyroidism
   • Low FT4 and FT3 confirm primary hypothyroidism
   • Presence of thyroid autoantibodies suggests autoimmune thyroiditis
5. Initiate treatment and monitoring:
   • Start levothyroxine replacement therapy
   • Monitor TSH and thyroid function tests regularly

Common Mistakes & Exam Traps

• The mistake: Failing to recognize myxedema coma as a life-threatening complication of untreated hypothyroidism.
• Why it happens: Misunderstanding the severity of hypothyroidism or neglecting to monitor thyroid function.
• How to avoid it: Recognize classic symptoms of hypothyroidism and monitor thyroid function regularly.
• Exam board insight: Failing to recognize myxedema coma can lead to a significant penalty on the exam.

How It’s Tested on USMLE

• Step 1: Basic science vignette (e.g., molecular mechanism, pathology slide, pharmacology)
• Step 2 CK: Clinical vignette (e.g., "A 45-year-old with chest pain..."). Focus on next step in diagnosis or treatment.
• Step 3: Similar to Step 2 CK, plus prognosis, risk factors, and occasionally CCS management.

CCS (Step 3) Relevance (If Applicable)

• Initial orders: Order TSH test, free T4 (FT4) and free T3 (FT3) tests, and thyroid autoantibodies.
• Monitoring and follow-up: Regularly monitor TSH and thyroid function tests to adjust levothyroxine dose as needed.
• Common mistakes: Failing to recognize myxedema coma or neglecting to monitor thyroid function.

Practice Questions (3-5 single-best-answer)

Question 1: A 35-year-old woman presents with dry skin, hair loss, and fatigue. Her TSH level is elevated at 12.5 mU/L. What is the next step in management?

Options: A) Start levothyroxine replacement therapy, B) Order free T4 (FT4) and free T3 (FT3) tests, C) Check thyroid autoantibodies, D) Refer to an endocrinologist

Answer: B) Order free T4 (FT4) and free T3 (FT3) tests

Explanation: To confirm the diagnosis of primary hypothyroidism and assess the severity of the condition.

Question 2: A 60-year-old man is diagnosed with myxedema coma. What is the most appropriate initial treatment?

Options: A) Levothyroxine replacement therapy, B) Hydrocortisone replacement therapy, C) Glucagon infusion, D) Vasopressin infusion

Answer: A) Levothyroxine replacement therapy

Explanation: Levothyroxine replacement therapy is the most effective treatment for myxedema coma.

Question 3: A 40-year-old woman is taking levothyroxine replacement therapy for primary hypothyroidism. Her TSH level is 0.5 mU/L. What is the next step in management?

Options: A) Increase levothyroxine dose, B) Decrease levothyroxine dose, C) Check free T4 (FT4) and free T3 (FT3) levels, D) Refer to an endocrinologist

Answer: B) Decrease levothyroxine dose

Explanation: A TSH level of 0.5 mU/L suggests hyperthyroidism, which is a contraindication for levothyroxine replacement therapy.

Quick Reference Card (60-Second Summary)

• Myxedema coma: Life-threatening complication of untreated hypothyroidism
• Levothyroxine (T4) replacement therapy: Corrects hypothyroidism and prevents complications
• TSH test: Elevated in primary hypothyroidism
• Free T4 (FT4) and Free T3 (FT3) tests: Low in primary hypothyroidism
• Thyroid autoantibodies: Presence suggests autoimmune thyroiditis

If You Get Stuck on Test Day

• Eliminate obviously wrong answers: Use the process of elimination to narrow down the options.
• Use the "next best step" hierarchy: Start with the least invasive and most specific option.
• For Step 3 CCS: Order basic labs, vitals, and IV access when unsure.

Related USMLE Topics

• Hyperthyroidism: Connects to thyroiditis, Graves' disease, and thyroid storm.
• Thyroid storm: Connects to hyperthyroidism, thyroiditis, and Graves' disease.
• Autoimmune thyroiditis: Connects to hypothyroidism, Hashimoto's thyroiditis, and thyroid antibodies.